缺血性心脑血管疾病患者血浆纤溶酶原激活物及纤溶酶原激活物抑制剂1的测定及临床意义
DOI:
作者:
作者单位:

作者简介:

通讯作者:

基金项目:


Clinical Analysis of Blood Plasma Levels of Urokinase-type Plasminogen Activator,Urokinase-type Plasminogen Activator Receptor,Tissue Piasm in Ogen Activator and,Plasminogen Activator Inhibitor 1 in Patients with Ischemic Cardio-Cerebral-Vascular Disease
Author:
Affiliation:

Fund Project:

  • 摘要
  • |
  • 图/表
  • |
  • 访问统计
  • |
  • 参考文献
  • |
  • 相似文献
  • |
  • 引证文献
  • |
  • 资源附件
    摘要:

    目的研究缺血性心脑血管疾病患者血浆尿激酶型纤溶酶原激活物及其受体、组织型纤溶酶原激活物及其抑制剂1的水平及意义。方法应用酶联免疫吸附试验测定急性脑梗死、急性心肌梗死及不稳定型心绞痛患者血浆尿激酶型纤溶酶原激活物及其受体、组织型纤溶酶原激活物及其抑制剂1的水平。结果(1)脑梗死患者急性期血浆尿激酶型纤溶酶原激活物轻度升高(p>0.05),恢复期明显回落(p<0.05),尿激酶型纤溶酶原激活物受体水平在急性期明显升高(p<0.01),恢复期进一步升高;血浆中组织型纤溶酶原激活物含量在急性期明显低于对照组(p<0.01),而纤溶酶原激活物抑制剂1含量则明显高于对照组(p<0.01),恢复期纤溶酶原激活物抑制剂1水平趋于正常,而血浆中组织型纤溶酶原激活物水平与对照组比较仍存在一定差异(p<0.05)。(2)急性心肌梗塞患者血浆尿激酶型纤溶酶原激活物受体水平急性期明显升高(p<0.05),恢复期进一步升高(p<0.01),尿激酶型纤溶酶原激活物水平均大致正常;急性期血浆中血浆中组织型纤溶酶原激活物及纤溶酶原激活物抑制剂1含量均明显高于对照组(p<0.01),恢复期明显回落,纤溶酶原激活物抑制剂1趋于正常,血浆中组织型纤溶酶原激活物水平仍高于对照组(p<0.05)。(3)不稳定型心绞痛患者急性期(入院时)血浆尿激酶型纤溶酶原激活物受体水平明显升高(p<0.01),恢复期(入院后二周)回落,但仍明显高于对照组(p<0.05),尿激酶型纤溶酶原激活物水平与对照组比较均未见明显差异(p>0.05);急性期血浆中组织型纤溶酶原激活物含量明显低于正常组(p<0.01),而纤溶酶原激活物抑制剂1含量略高于对照组(p>0.05),恢复期两者含量均趋于正常(p>0.05)。结论缺血性心脑血管疾病患者存在不同程度的凝血纤溶系统失平衡,对疾病的发生发展起重要作用。

    Abstract:

    Aim To study the blood plasma levels and significance of uPA,u-PAR,t-PA and PAI-1 in patients with ischemic cardio-cerebral-vascular disease.Methods ELISA was used to measure the blood plasma levels of uPA,uPAR,t-PA and PAI-1 in patients with acute cerebral infarction,acute myocardial infarction and unstable angina pectoris.Results Compared with the control group,(1)uPA level increased slightly at acute stage in patients with cerebral infarction(p> 0.05),while obviously fell back at restoration stage(p< 0.05);uPA level increased significantly at acute stage(p< 0.01)and increased more;t-PA level was obviously lower(p< 0.01),while PAI-1 significantly higher(p< 0.01) at acute stage;PAI-1 decreased to normal level while t-PA level was different from the control group at restoration stage.(2)u-PAR level increased obviously at acute stage(p< 0.05)and increased more at restoration stage(p< 0.01) in patients with acute myocardial infarction,uPA levels were nearly normal at both stages;t-PA and PAI1 levels were obviously higher at acute stage(p< 0.01) but decreased obviously at restoration stage till a normal PAI-1 level and a still higher level of t-PA (p< 0.05).(3)u-PAR level increased in patients with unstable angina pectoris at acute stage(P <0.01) while fell back at restoration stage after two weeks

    参考文献
    相似文献
    引证文献
引用本文

周欢琴,谢海宝,肖震,翁秀妹,叶雄伟.缺血性心脑血管疾病患者血浆纤溶酶原激活物及纤溶酶原激活物抑制剂1的测定及临床意义[J].中国动脉硬化杂志,2007,15(12):920~922.

复制
分享
文章指标
  • 点击次数:
  • 下载次数:
历史
  • 收稿日期:2007-05-23
  • 最后修改日期:2007-11-16
  • 录用日期:
  • 在线发布日期: